Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Relapsed Hairy Cell Leukemia
NCT00003757Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Feb 1998
- Primary completion
- Jul 2002
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in hairy cell leukemia (HCL), sponsored by Swiss Group for Clinical Cancer Research. Started Feb 1998; status: completed.
02
Drugs
rituximab
03
Conditions
hairy cell leukemia (HCL)
Beyond the preview
Go deeper on NCT00003757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003757.